Does radiomics have added value in predicting the development of brain metastases in patients with radically treated stage III non-small cell lung cancer (NSCLC)?

Authors :: Hendriks, L.
Keek, S. A.
Chatterjee, A.
Belderbos, J.
Bootsma, G.
van den Borne, B.
Dingemans, A-M. C.
Gietema, H.
Groen, H. J. M.
Herder, G.
Pitz, C.
Praag, J.
De Ruysscher, D.
Schoenmaekers, J.
Smit, H. J. M.
Stigt, J.
Westenend, M.
Zeng, H.
Woodruff, H.
Lambin, P.
Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Damage and Repair in Cancer Development and Cancer Treatment (DARE)
Source :: Annals of Oncology, 33, S91-S91. Oxford University Press
Publication Year :: 2022

Tools